PKU HealthCare Corp.,Ltd.
As of 17 November 2026, for the company name PKU HealthCare Corp.,Ltd. as recorded, 6 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 49 records, across 29 drug names; since 21 August 2026, the records list Accepted: 2 applications, No longer listed under review: 1 application; the chemical-drug catalogue lists 36 active records with this name as holder; 24 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
49 acceptance records as first applicant, grouped into 29 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2026/09/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602299 | Generic | 2026/09/16 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2026/09/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602219 | Generic | 2026/09/07 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Lurasidone Hydrochloride Tablets 2 records · Latest accepted 2026/05/14
Generic · 2
Moxifloxacin Hydrochloride Tablets 2 records · Latest accepted 2026/01/12
Generic · 2
Paracetamol and Ibuprofen Tablets 1 records · Latest accepted 2025/12/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502455 | Supplement | 2025/12/02 | PKU HealthCare Corp.,Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
硫酸艾沙康唑胶囊 · No verified English name 1 records · Latest accepted 2025/09/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503543 | Generic | 2025/09/28 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets 3 records · Latest accepted 2025/07/15
Supplement · 1Generic · 2
Olanzapine Tablets 2 records · Latest accepted 2025/07/08
Supplement · 1Generic · 1
Tofacitinib Citrate Extended Release tablets 1 records · Latest accepted 2025/06/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502027 | Generic | 2025/06/07 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2025/05/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501659 | Generic | 2025/05/08 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Paliperidone Extend-release Tablets 2 records · Latest accepted 2025/02/09
Generic · 2
Quetiapine Fumarate Extended-release Tablets 4 records · Latest accepted 2025/01/14
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500094 | Supplement | 2025/01/14 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| CYHB2500013 | Supplement | 2025/01/03 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| CYHS2301283 | Generic | 2023/05/12 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| CYHS2301282 | Generic | 2023/05/12 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2024/11/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401866 | Supplement | 2024/11/12 | PKU HealthCare Corp.,Ltd.; Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Ondansetron Hydrochloride Tablets 1 records · Latest accepted 2024/08/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450427 | Supplement | 2024/08/09 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
阿普米司特片 · No verified English name 2 records · Latest accepted 2024/07/27
Generic · 2
Loratadine Tablets 2 records · Latest accepted 2024/02/28
Supplement · 2
注射用头孢唑肟钠 · No verified English name 2 records · Latest accepted 2024/01/08
Supplement · 2
Buspirone Hydrochloride Tablets 2 records · Latest accepted 2023/11/08
Supplement · 2
Vortioxetine Hydrobromide Tablets 3 records · Latest accepted 2023/07/15
Generic · 3
Clindamycin Palmitate Hydrochloride Granules 2 records · Latest accepted 2023/07/11
Supplement · 2
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2023/06/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301320 | Supplement | 2023/06/13 | PKU HealthCare Corp.,Ltd.; Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Levocetirizine dihydrochloride Oral Solution 2 records · Latest accepted 2023/01/12
Generic · 2
Palonosetron Hydrochloride Injection 1 records · Latest accepted 2022/04/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250216 | Supplement | 2022/04/18 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Cefotaxime Sodium For Injection 2 records · Latest accepted 2022/01/12
Supplement · 2
Trimetazidine Dihydrochloride Modified Release Tablets 1 records · Latest accepted 2021/12/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2102255 | Supplement | 2021/12/07 | PKU HealthCare Corp.,Ltd.; Beijing Bai Mei Te Biopharmaceutical Co., Ltd. romanized | CDE ↗ |
Tandospirone Citrate Tablets 2 records · Latest accepted 2021/11/19
Generic · 2
Ornidazole Injection 2 records · Latest accepted 2021/06/28
Generic · 2
Compound Sulfamethoxazole Tablets 1 records · Latest accepted 2021/01/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150036 | Supplement | 2021/01/16 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Ambroxol Hydrochloride Injection 1 records · Latest accepted 2021/01/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2000956 | Generic | 2021/01/01 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 2 applicationsNo longer listed under review: 1 application
- 2026/11/03No longer listed under review
Tofacitinib Citrate Extended Release tablets
CYHS2502027
Fact date: 2026/11/03 · Date added to this site: 2026/11/03
Accepted: 2025/06/07
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/09/16Accepted
Upadacitinib Sustained-release Tablets
CYHS2602299
Fact date: 2026/09/16 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/07Accepted
Oseltamivir Phosphate Capsules
CYHS2602219
Fact date: 2026/09/07 · Date added to this site: 2026/10/22
View source ↗
Under review
6 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Upadacitinib Sustained-release Tablets | CYHS2602299 | Generic | 2026/09/16 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| Oseltamivir Phosphate Capsules | CYHS2602219 | Generic | 2026/09/07 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| Lurasidone Hydrochloride Tablets | CYHS2601157 | Generic | 2026/05/14 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| Lurasidone Hydrochloride Tablets | CYHS2601156 | Generic | 2026/05/14 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| Moxifloxacin Hydrochloride Tablets | CYHS2600143 | Generic | 2026/01/12 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
| 硫酸艾沙康唑胶囊 · No verified English name | CYHS2503543 | Generic | 2025/09/28 | PKU HealthCare Corp.,Ltd. | CDE ↗ |
Catalogue holder records
36 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Paliperidone Extend-release Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20264823 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paliperidone Extend-release Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20264822 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Quetiapine Fumarate Extended-release Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20258270 | 2025/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20258218 | 2025/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20255528 | 2025/09/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20255527 | 2025/09/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ondansetron Hydrochloride Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H10970155 | 2025/04/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20090072 | 2025/03/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20090071 | 2025/03/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Buspirone Hydrochloride Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H19990302 | 2024/12/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Buspirone Hydrochloride Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20247318 | 2024/12/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20249356 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20249358 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Quetiapine Fumarate Extended-release Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20249352 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20249357 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20249181 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palonosetron Hydrochloride Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20130108 | 2023/09/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tandospirone Citrate Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20233343 | 2023/03/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tandospirone Citrate Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20233342 | 2023/03/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20223770 | 2022/10/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20223769 | 2022/10/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Loratadine Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20040784 | 2022/09/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olanzapine Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20223516 | 2022/07/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ambroxol Hydrochloride Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20223257 | 2022/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Compound Sulfamethoxazole Tablets | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H50020557 | 2022/03/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Meropenem for Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20093264 | 2021/10/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Meropenem for Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20093263 | 2021/10/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Celecoxib Capsules | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20213717 | 2021/09/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefminox Sodium for Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20056298 | 2021/09/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20056297 | 2021/09/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H10910033 | 2021/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H50020276 | 2021/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H50020275 | 2021/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H50021800 | 2023/01/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H50020491 | 2023/01/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rosuvastatin Calcium and Ezetimibe Tablets (I) | PKU HealthCare Corp.,Ltd. | PKU HealthCare Corp.,Ltd. | 国药准字H20266204 | 2026/10/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
24 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸鲁拉西酮 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20250000614 | I | 2025/06/24 | CDE ↗ |
| 枸橼酸托法替布 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20240001104 | A | 2026/04/29 | CDE ↗ |
| 帕利哌酮 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20240000871 | A | 2026/09/21 | CDE ↗ |
| 氢溴酸伏硫西汀 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20230000027 | A | 2024/07/17 | CDE ↗ |
| 萘丁美酮 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20180001801 | A | 2024/02/05 | CDE ↗ |
| 格列美脲 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190007785 | A | 2025/04/02 | CDE ↗ |
| 米力农 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190007401 | A | 2023/12/23 | CDE ↗ |
| 盐酸帕洛诺司琼 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190007327 | A | 2023/08/29 | CDE ↗ |
| 奥氮平 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190006557 | A | 2026/03/06 | CDE ↗ |
| 枸橼酸坦度螺酮 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190006503 | A | 2026/03/06 | CDE ↗ |
| 卡维地洛 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190005364 | A | 2025/08/08 | CDE ↗ |
| 盐酸丁螺环酮 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190002254 | A | 2025/04/02 | CDE ↗ |
| 盐酸格拉司琼 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190002252 | A | 2025/04/02 | CDE ↗ |
| 盐酸昂丹司琼 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190002237 | A | 2025/09/01 | CDE ↗ |
| 盐酸克林霉素棕榈酸酯 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190001954 | A | 2025/04/02 | CDE ↗ |
| 右旋酮洛芬 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20190001332 | A | 2024/02/05 | CDE ↗ |
| 曲昔派特 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170002197 | A | 2024/02/05 | CDE ↗ |
| 埃索美拉唑钠 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170001691 | I | — | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170001426 | A | 2024/08/27 | CDE ↗ |
| 阿戈美拉汀 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170000370 | I | — | CDE ↗ |
| 酮亮氨酸钙 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170000272 | I | — | CDE ↗ |
| 酮缬氨酸钙 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170000271 | I | — | CDE ↗ |
| 酮苯丙氨酸钙 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170000270 | I | — | CDE ↗ |
| 消旋酮异亮氨酸钙 · No verified English name | PKU HealthCare Corp.,Ltd. | Y20170000269 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.